Referable Macular Hemorrhage-A Clinically Meaningful Screening Target in Newborn Infants. Position Statement of the Association of Pediatric Retina Surgeons

Edward H. Wood, Antonio Capone, Kimberly A. Drenser, Audinal Berrocal, G. Baker Hubbard, Natalia F. Callaway, Andres Kychenthal, Anna Ells, Clio A. Harper, Cagri Giray Besirli, Caroline R. Baumal, Demetrios G. Vavvas, Emmanuel Y. Chang, Eric D. Nudleman, Irena Tsui, Jonathan Sears, Lejla Vajzovic, Mary E. Hartnett, Michael J. Shapiro, Polly A. QuiramSengul Ozdek, Shunjil Kusaka, Wei Chi Wu, Michael T. Trese

Research output: Contribution to journalReview articlepeer-review

Abstract

Universal newborn eye screening facilitates early diagnosis of ocular abnormalities and mitigates vision loss. “Referral warranted” eye disease is present at birth in about 5.5% of term infants, with “macular hemorrhage impinging on the fovea” representing about 50% of referral warranted disease. The Association of Pediatric Retina Surgeons held a symposium on February 9, 2021 that culminated in a position statement on “referable macular hemorrhage” (RMH) in newborn infants. RMH is meaningful in that in can cause amblyopia through deprivation, can be readily captured with wide-angle photography in a safe and efficient manner, and may lead to early intervention with mitigation of vision loss.

Original languageEnglish (US)
Pages (from-to)3-6
Number of pages4
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume53
Issue number1
DOIs
StatePublished - Jan 2022
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Fingerprint

Dive into the research topics of 'Referable Macular Hemorrhage-A Clinically Meaningful Screening Target in Newborn Infants. Position Statement of the Association of Pediatric Retina Surgeons'. Together they form a unique fingerprint.

Cite this